Volume 30, Issue 5 pp. 1083-1091
Full Paper

Synthesis and Anti-tumor Evaluation of Novel C-37 Modified Derivatives of Gambogic Acid

Xiang Li

Xiang Li

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 21009, China

Search for more papers by this author
Xiaojin Zhang

Xiaojin Zhang

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 21009, China

Search for more papers by this author
Haopeng Sun

Corresponding Author

Haopeng Sun

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 21009, China

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China, Tel.: 0086-025-83271351; Fax: 0086-025-83271351Search for more papers by this author
Lei Zhang

Lei Zhang

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 21009, China

Search for more papers by this author
Yuan Gao

Yuan Gao

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China

Search for more papers by this author
Jinxin Wang

Jinxin Wang

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 21009, China

Search for more papers by this author
Qinglong Guo

Qinglong Guo

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China

Search for more papers by this author
Qidong You

Corresponding Author

Qidong You

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 21009, China

Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China

State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, Jiangsu 210009, China, Tel.: 0086-025-83271351; Fax: 0086-025-83271351Search for more papers by this author
First published: 07 May 2012
Citations: 10

Abstract

Gambogic acid (GA, 1), the most prominent representative of Garcinia natural products, has been reported to be a promising anti-tumor agent. In order to further explore the structure-activity relationship of GA and discover novel GA derivatives as anti-tumor agents, 17 novel C-37 modified derivatives of GA were synthesized and evaluated for their in vitro anti-tumor activities against A549, HCT-116, BGC-823, HepG2 and MCF-7 cancer cell lines. Among them, 11 compounds were found to be more potent than GA against some cancer cell lines. Notably, compound 8 was almost 5–10 folds more active than GA against A549 and BGC-823 cell lines with the IC50 values of 0.12 µmol·L−1 and 0.57 µmol·L−1, respectively. Chemical modification at C-37 position of GA by introducing of hydrophilic amines could lead to increased activity and improved drug-like properties. These findings will enhance our understanding of the structure-activity relationship (SAR) of GA and lead to the discovery of novel GA derivatives as potential anti-tumor agents.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.